Paragon Capital Management LLC Amgen Inc Transaction History

Paragon Capital Management LLC

  • $183 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020
SELL
$197.81 - $242.74 $61,914 - $75,977
-313 Closed
0 $0
Q1 2020

May 01, 2020
BUY
$182.24 - $241.7 $57,041 - $75,652
313 New
313 $63,000
Q3 2019

Oct 31, 2019
SELL
$174.11 - $208.62 $54,496 - $65,298
-313 Closed
0 $0
Q1 2019

Apr 15, 2019
BUY
$180.87 - $203.88 $56,612 - $63,814
313 New
313 $59,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Paragon Capital Management LLC Portfolio

Follow Paragon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email